We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Oxford, UK-based Genomics plc has completed a $30m funding round, which the company will use to expand its work on its patient-centric, population health platform.
Foresite Capital surpassed its $650 million goal to close its largest fund yet, with $668 million in capital commitments. While the firm doesn't limit itself by therapeutic area...